Corcept Therapeutics | CORT - Ebit



金融业
股票价格
USD
资产
USD 888.7M
现金及等价物
USD 111.04M
销售成本
USD 4.06M
流动资产
USD 439.68M
流动负债
USD 153.8M
债务
USD 9.64M
EBIT
USD 41.3M
EBITDA
USD -49M
员工
500
EPS每股收益
USD 0.36
股本和储备
USD 705.78M
销售毛利
USD 252.09M
债务利息支出
USD 888.7M
利息收入
USD 4.89M
市值
USD 12.44B
净收入
USD 42.14M
营业费用
USD 214.85M
营业利润
USD 41.3M
普通股股本
USD 107.33M
PE价格收益
188.23
税前利润
USD -44.72M
销售收入
USD 256.15M
销售和管理费用
USD 156.9M
股票
USD 13.19M
贸易债权人
USD 14.91M
应收帐款人
USD 76.92M


Ebit 更改 日
Acadia Pharmaceuticals USD -4.62M 22.01M 2026-03
Alaunos Therapeutics USD -1.01M 175K 2026-03
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Ardelyx USD -30.68M 35.78M 2026-03
Aurora Cannabis CAD 7.12M 42.91M 2026-03
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Canopy Growth CAD -145.65M 132.99M 2026-03
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Eli Lilly USD 9.78B 792M 2026-03
J&J USD 7.48B 860M 2026-06
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Merck USD -1.88B 8.12B 2026-03
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.73B 549M 2026-06
Novartis USD 4.18B 118M 2026-03
Omeros USD -48.15M 7.25M 2023-09
Pacira USD 4.62M 1.43M 2026-03
Pfizer USD 4.99B 340M 2026-03
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03